AMANDA BORDEN: Open Payments
NPI 1285987610 · WEST READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 44 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $290 |
| AstraZeneca Pharmaceuticals LP | 9 | $193 |
| ABBVIE INC. | 9 | $153 |
| Lilly USA, LLC | 6 | $143 |
| Janssen Pharmaceuticals, Inc | 3 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
Products named: JARDIANCE, Rybelsus, UBRELVY, AIRSUPRA, SPRAVATO, Ozempic, FARXIGA, QULIPTA.
Industry payments across PA — which companies pay providers there.
